Edwards Lifesciences (NYSE: EW) posted first-quarter results today that beat the consensus forecast on Wall Street. It also reaffirmed its outlook for the rest of the year, with CEO Michael Mussallem saying, “We are hopeful the worst of the pandemic is behind us.” The Irvine, California–based cardio device company reported profits of $373.6 million, or […]